100%
Skip to main content
Platform
GovTribe AI
AI-powered insights to accelerate your government contracting workflow.
MCP Server
Connect GovTribe to your AI tools.
Beacon
Find and connect with key government decision-makers.
Profiles
Federal Agencies
Federal Contract Vehicles
Federal Grant Programs
Major Defense Acquisition Programs
NAICS Categories
PSC Categories
States
Jurisdictions
NIGP Categories
UNSPSC Categories
Vendors
Enrichment By Clearbit
Reports
New Entrants
Funding Analysis
Vehicle Analysis
Groups
Capture
Pipelines
Pursuits
Alerts
Teaming
Data
Awards
Forecasts
Federal Opportunities
State & Local Opportunities
Files
Prime and Subcontractors
Activity
Search
Exports
Solutions
Use Case
Opportunity Identification
Capture Management
Competitive Intelligence
Teaming & Partner Identification
Proposal Management
Strategic Leadership
Go-to-Market Strategy
Industry
Federal Contractors
State & Local Contractors
Grant Seekers
Government Agencies
Research & Consulting
Pricing
More
About Us
Features
Get A Demo
Sign Up
Blog
User Guide
Data Model
GovTribe for Agents
Login
Contact sales
Try for free
Login
Contact sales
Try for free
All Federal Contract Awards
Purchase Order 75N90020P00258
Award Date
2/28/20
Potential Completion Date
2/27/21
Potential Value
Not listed
Overview
Contacts
Activity
2
Transactions
2
Subawards
Opportunity Stack
Similar Awards
Federal Agency
NIH Clinical Center
Awardee
Bionique Testing Laboratories LLC VH8MZDMD3BL1
Ultimate Awardee
Not listed
NAICS Category
541380 - Testing Laboratories and Services
PSC Category
Q301 - Reference Laboratory Testing
Federal Contract Vehicle
Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Saranac Lake, NY, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Update #1
Update #2
BIONIQUE TESTING LABORATORIES, INC.:1308160 [20-003365]
Posted 2/28/20
5
1
Name
Description
Solicitation Number
FederalAgency
Type
PostedDate
Mycoplasma testing of cell therapy products for Clinical Center patients.
INTRODUCTION THIS IS A PRE-SOLICITATION NON-COMPETITIVE (NOTICE OF INTENT) SYNOPSIS TO AWARD A CONTRACT OR PURCHASE ORDER WITHOUT PROVIDING FOR FULL OR OPEN COMPETITION (INCLUDING BRAND-NAME). The National Institutes of Health (NIH), Clinical Center (CC), Office of Purchasing and Contracts (OPC) on behalf of the Department of Laboratory Medicine (DLM), Clinical Center (CC) at the National Institutes of Health (NIH) intends to negotiate and award a contract without providing for full and open competition (Including brand-name) to: BIONIQUE TESTING LABORATORIES, INC. 156 FAY BROOK DR SARANAC LAKE, NY, 12983-5802, UNITED STATES NORTH AMERICAN INDUSTRY CLASSIFICATION SYSTEM (NAICS) CODE The intended procurement is classified under NAICS code 541380 with a Size Standard $16.5 million. REGULATORY AUTHORITY The resultant contract will include all applicable provisions and clauses in effect tough the Federal Acquisition Circular (FAC) 2020-02 December 23, 2019. This acquisition is conducted under the procedures as prescribed in FAR subpart 13-Simplified Acquisition Procedures at an amount not exceeding the simplified acquisition teshold ($250,000). STATUTORY AUTHORITY This acquisition is conducted under the authority of the Federal Acquisition Regulation (FAR) Part 13-Simplified Acquisition Procedures, Subpart 13.106-1 (b) (1), Soliciting from a single source and is not expected to exceed the simplified acquisition teshold. Contracts awarded using FAR Part 13-Simplified Acquisition Procedures are exempt from the requirements of FAR Part 6-Competition Requirements. GENERAL INFORMATION 1. Title: Mycoplasma testing of cell therapy products for Clinical Center patients. 2. Background Information: The Department of Laboratory Medicine serves as the clinical laboratory of the NIH Clinical Center. It provides laboratory support for patient care and research protocols and performs research and training in disciplines of Clinical Pathology. In doing so it provides state-of-the-art laboratory testing in support of Clinical Center patient care and serves as a center of excellence in research and training in laboratory medicine, particularly in areas which utilize the unique strengths of the National Institutes of Health. 3. Purpose or Objective: Mycoplasma testing of cell therapy products for Clinical Center patients. 4. Period of Performance: One (1) year beginning on or around 2/1/2020. CONTRACTOR REQUIREMENTS (SCOPE OF WORK) Independently, and not as an agent of the government, the contractor shall provide necessary personnel, supplies, and services to perform the work required below: Real-time Direct qPCR Mycoplasma testing and USP<63> Mycoplasma culture that is compliant with the culture-based compendial method (1993 FDA Points to Consider) method for the testing of cell therapy products performed in a cGMP FDA certified laboratory. Testing should consist of the following validated platforms with supporting documentation available for FDA and end-user audit: Real-time qPCR based on Applied Biosystems MycoSEQ Mycoplasma Detection Kit and using Applied Biosystems 7500 Real-time PCR sustems Nucleic acid extraction using PrepSEQ Validated testing systems using intact, viable mycoplasma and not previously purified genomic DNA Demonstrated equivalence of real time qPCR method to culture-based compendia method (1993 FDA Points to Consider method) available upon execution of corporate non-disclosure agreement Limit of detection of most Mycoplasma species at 10 CFU/ml 10 CFU/ml A. laidlawii in CHO 10 CFU/ml M. hyorhinis in CHO 10 CFU/ml M. orale in CHO 80 CFU/ml M. pneumoniae in CHO Defined procedures for suitability testing of the product Periodic performance evaluation and inter-laboratory comparison studies Guaranteed turnaround time to final report within 5 days of sample submission for PCR USP<63> Mycoplasma culture Guaranteed turnaround time to final report within 40 days of sample submission for culture Notification of positive results CONTRACTING WITHOUT PROVIDING FOR FULL OR OPEN COMPETITION (INCLUDING BRAND-NAME) DETERMINATION This is a requirement for testing from a testing laboratory. Bionique Testing Laboratories, Inc. is the only known cGMP FDA certified facility that provided an identical testing platform to the one used in the NIH CC DLM Sterility Testing Service. This is critical for test method validation purposes and to ensure accuracy and comparability of results from in-house testing and vendor testing. The determination by the Government to award a contract without providing for full and open competition is based upon the market research conducted as prescribed in FAR Part 10-Market Research. CLOSING STATEMENT This synopsis is not a request for competitive proposals. However, interested parties may identify their interest and capability to respond to this notice. Responses to this notice shall contain sufficient information to establish the interested parties' bona-fide capabilities for fulfilling the requirement and include a technical proposal, a cost-price proposal, the period of performance, the Dun & Bradstreet Number (DUNS), the Taxpayer Identification Number (TIN), and the certification of business size. All offerors must have an active registration in the System for Award Management (SAM) www.sam.gov. A determination by the Government not to compete this proposed contract based upon responses to this notice is solely within the discretion of the Government. The information received will normally be considered solely for the purposes of determining whether to proceed on a non-competitive basis or to conduct a competitive procurement. All responses must be received by January 29, 2020, 03:00 PM Eastern time and must reference solicitation number 20-003365. Responses may be submitted electronically to Mr. Cistopher Lauver, Contracting Specialist at cistopher.lauver@nih.gov. Fax responses will not be accepted. "All responsible sources may submit a capability statement, proposal, or quotation, which shall be considered by the agency."
20-003365
Department of Health and Human Services National Institutes of Health Clinical Center
Pre-Solicitation 1/1
2/5/20, 11:19 AM
5
1
Mod #
Description
ReasonForModification
Federal Obligation
Date
P00001
BIONIQUE TESTING LABORATORIES, INC.:1308160 [20-003365]
Funding Only Action
($75k)
8/13/20
Not listed
BIONIQUE TESTING LABORATORIES, INC.:1308160 [20-003365]
Not listed
$75.0k
2/28/20